Showing results (451-460 of 490) with videos related to

Sort By:
Pageof 49
JAMA|May 13, 2010
Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemiaElliott P Vichinsky, Lynne D Neumayr, Jeffrey I Gold, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseasesJonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
ACS Chemical Biology|July 20, 2016
Facile Modulation of Antibody Fucosylation with Small Molecule Fucostatin Inhibitors and Cocrystal Structure with GDP-Mannose 4,6-DehydrataseJohn G Allen, Mirna Mujacic, Michael J Frohn, et al.
Blood Advances|December 3, 2025
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: The REAL-HLH studyAdi Zoref-Lorenz, Carl E Allen, Edward M Behrens, et al.
JAMA Network Open|December 15, 2023
Guiding Principles to Address the Impact of Algorithm Bias on Racial and Ethnic Disparities in Health and Health CareMarshall H Chin, Nasim Afsar-Manesh, Arlene S Bierman, et al.
Blood|November 8, 2012
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomesRebecca A Marsh, Kanchan Rao, Prakash Satwani, et al.
Blood Advances|March 1, 2024
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabShanmuganathan Chandrakasan, Michael B Jordan, Ashley Baker, et al.
Journal of AOAC International|August 31, 2017
Detection of Paralytic Shellfish Toxins in Mussels and Oysters Using the Qualitative Neogen Lateral-Flow Immunoassay: An Interlaboratory StudyJuan José Dorantes-Aranda, Jessica Y C Tan, Gustaaf M Hallegraeff, et al.
NAR Cancer|July 28, 2021
Erratum: Ribosomal RNA 2' O-methylation as a novel layer of inter-tumour heterogeneity in breast cancerVirginie Marcel, Janice Kielbassa, Virginie Marchand, et al.
Oncotarget|August 18, 2015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancerMeng-Lay Lin, Hetal Patel, Judit Remenyi, et al.
Pageof 49